When you sign up for a GLP-1 telehealth platform, you probably think you're dealing with one company. In reality, most platforms operate through a three-entity structure: a technology and marketing company that runs the website and customer experience, a separate clinical entity (a professional corporation or PLLC) that employs or contracts the prescribers, and one or more partner pharmacies that compound and ship the medication.
This isn't inherently problematic — it's how healthcare regulation works. But when things go wrong — a shipment is late, your prescription needs adjustment, or you have a clinical question — the three-entity model can mean nobody takes ownership because each entity points to the others.
The Three Entities, Explained
Entity 1: The Technology / Marketing Company
This is the brand you see — the website, the app, the social media presence, the checkout experience. This entity handles customer acquisition, payment processing, user experience, and brand management. It's usually a standard LLC or corporation, not a healthcare entity. It's regulated primarily by the FTC (for advertising claims) and state consumer protection laws.
Importantly, this entity does not prescribe medication, practice medicine, or dispense drugs. It connects you to the entities that do.
Entity 2: The Clinical Entity
This is the professional corporation (PC) or professional limited liability company (PLLC) that employs or contracts the clinicians who evaluate your case and write prescriptions. In many states, medical practices must be owned by licensed physicians, which is why this entity is structurally separate from the tech company.
The prescriber who reviews your intake form — whether an MD, DO, NP, or PA — is credentialed through this entity, not the brand you signed up with. Their licensing, malpractice coverage, and regulatory obligations flow through the clinical entity.
Entity 3: The Pharmacy
The compounding or dispensing pharmacy that prepares and ships your medication operates independently from both the tech company and the clinical entity. The pharmacy has its own licensing (state pharmacy board plus FDA registration for 503B facilities), its own quality controls, and its own regulatory obligations.
Why This Structure Exists
The three-entity model isn't a scheme to hide accountability — it's a consequence of healthcare regulation. Most states prohibit the corporate practice of medicine (CPOM), meaning non-medical companies can't directly employ physicians or control clinical decisions. The structural separation between the tech company and the clinical entity exists specifically to protect clinical independence.
Similarly, pharmacy law requires that medications be dispensed by licensed pharmacies under pharmacist supervision. The tech company can't legally ship you drugs directly.
The model works well when all three entities communicate effectively and share accountability. It fails when they don't.
The Questions You Should Be Asking
When evaluating any GLP-1 telehealth platform, trace the full path from your intake form to the medication in your fridge:
- Who is the clinical entity? What's the name of the PC or PLLC that manages your care? Is it identifiable on the platform, or buried in fine print?
- Who is your prescriber? Can you find their name, credentials, and state licensure? Have they ever had a synchronous conversation with you (video, phone), or was the entire evaluation asynchronous?
- Which pharmacy fills your prescription? Can you independently verify the pharmacy's state license and, for compounding pharmacies, their FDA registration status (503A or 503B)?
- Is the pharmacy LegitScript-certified? LegitScript certification is an independent verification that the pharmacy meets regulatory standards for online pharmacy operations.
- Who do you contact with clinical questions? If you have a side effect or concern, does your message go to the tech company's customer service team, or do you have a channel to reach a clinician directly?